A Focus on Gastrointestinal Cancers

Monday, December 4, 2023 | 1-5 P.M. ESt
Live via Zoom Webinar

Join SITC and a panel of experts for an afternoon of in-depth education on all aspects of clinical implementation of immunotherapy for gastrointestinal cancers.

Register Now

Program Organizers


Paige Griffith, MSN, AG-ACNP, BSN
Johns Hopkins University


Suwicha Limvorasak, PharmD
Cedars Sinai Medical Center


Arsen Osipov, MD
Cedars Sinai Medical Center


Mark Yarchoan, MD
Johns Hopkins Medicine

Program Agenda - Coming Soon

Program Details

Target Audience

The Advances in Cancer Immunotherapy™ (ACI) programs aim to reach practicing clinical oncologists, nurses, nurse practitioners, advanced practitioners, pharmacists, emergency physicians, and other allied health professionals who wish to learn the basic principles of cancer immunotherapy and the most up-to-date clinical data for these treatments, in a multitude of disease states/therapeutic areas, in order to inform and integrate into their own clinical practice. In-training oncologists and hospital administrators will also find the program beneficial.

Case Study Submission Information

As part of the program, registrants are encouraged to submit case studies for expert review during the case study panel concluding the program. If you are interested in taking advantage of this opportunity, please review and sign the linked case study guidelines, and return your case study and signed guidelines to education@sitcancer.org.

Program Learning Objectives

  • Identify the cancer immunotherapy approaches in use for the treatment of gastrointestinal cancers.

  • Summarize recent updates in cancer immunotherapy for gastrointestinal cancers including emerging toxicities and management.

  • Implement cancer immunotherapy for gastrointestinal cancer into clinical practice appropriately.

Accreditation Information

Joint Accreditation Statement

thumbnail image In support of improving patient care, this activity has been planned and implemented by Partners for Advancing Clinical Education (PACE) and the Society for Immunotherapy of Cancer (SITC).  PACE is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC)

Credit information to be determined. ABIM_Logo.jpg





Physician Continuing Medical Education

Credit information to be determined

Continuing Pharmacy Education

Credit information to be determined.

Continuing Nursing Education

Credit information to be determined.

Disclosures and ADA Info

Disclosure of Conflicts of Interest

PACE requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial relationships they may have with ineligible companies. All relevant financial relationships are thoroughly vetted and mitigated according to PACE policy. PACE is committed to providing learners with high-quality accredited CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Americans with Disabilities Act

Event staff will be glad to assist you with any special needs (i.e., physical, dietary, etc). Please contact SITC Staff prior to the live event at (414) 271-2456 or via email education@sitcancer.org.